Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000388755 | SCV000426958 | uncertain significance | Familial hypobetalipoproteinemia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000296802 | SCV000426959 | uncertain significance | Hypercholesterolemia, familial, 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356457 | SCV002621633 | uncertain significance | Cardiovascular phenotype | 2024-05-22 | criteria provided, single submitter | clinical testing | The p.I3855V variant (also known as c.11563A>G), located in coding exon 26 of the APOB gene, results from an A to G substitution at nucleotide position 11563. The isoleucine at codon 3855 is replaced by valine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |